Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
Authors
Keywords
-
Journal
CANCER
Volume 122, Issue 6, Pages 875-883
Publisher
Wiley
Online
2015-12-28
DOI
10.1002/cncr.29856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer
- (2015) Devalingam Mahalingam et al. BMC CANCER
- Abstract 5355: Oncolytic viral therapy with immune modulation is an effective novel treatment strategy for non-small cell lung cancer
- (2015) Jianrui Liu et al. CANCER RESEARCH
- The oncolytic virus, pelareorep, as a novel anticancer agent: a review
- (2015) Romit Chakrabarty et al. INVESTIGATIONAL NEW DRUGS
- Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib
- (2015) Justin F. Gainor et al. Journal of Thoracic Oncology
- BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress
- (2015) Victoria Roulstone et al. MOLECULAR THERAPY
- Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan
- (2015) Radhashree Maitra et al. Oncotarget
- The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer
- (2014) Conor E. Steuer et al. CANCER
- A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
- (2014) D. W. Sborov et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors
- (2014) V. Roulstone et al. CLINICAL CANCER RESEARCH
- Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non–Small-Cell Lung Cancer Segregated According to KRAS Mutation Status
- (2013) Giulio Metro et al. Clinical Lung Cancer
- KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer
- (2013) Petra Martin et al. Journal of Thoracic Oncology
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
- (2012) E. M. Karapanagiotou et al. CLINICAL CANCER RESEARCH
- Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples
- (2012) Gerard J Nuovo et al. MODERN PATHOLOGY
- Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
- (2012) Evanthia Galanis et al. MOLECULAR THERAPY
- Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients
- (2012) R. A. Adair et al. Science Translational Medicine
- Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
- (2011) Kenneth J O'Byrne et al. LANCET ONCOLOGY
- A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
- (2010) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer
- (2010) C. Comins et al. CLINICAL CANCER RESEARCH
- Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
- (2009) Radharani Gollamudi et al. INVESTIGATIONAL NEW DRUGS
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
- (2009) Shizuko Sei et al. Molecular Cancer
- A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
- (2008) L. Vidal et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
- (2008) C L White et al. GENE THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started